N-acetyl-glucosaminidase inhibitors (Dorphan)

N/A

Report date: 2025/03/20 20:00:06

NME

Base Information

Drug NameN-acetyl-glucosaminidase inhibitors (Dorphan)

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionAlpha-N-acetylglucosaminidase inhibitors

TargetsAlpha-N-acetylglucosaminidase

Therapy Area/IndicationsMucopolysaccharidosis III

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySwitzerland

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesDorphan SA

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesDorphan SA

Active IndicationsN/A

Inactive IndicationsMucopolysaccharidosis III

ATC CodeN/A